Kennedy Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-33,586
| Closed | -$1.41M | – | 711 |
|
|
2024
Q1 | $1.41M | Sell |
33,586
-28,586
| -46% | -$1.2M | 0.03% | 581 |
|
|
2023
Q4 | $2.47M | Sell |
62,172
-25,222
| -29% | -$1M | 0.05% | 451 |
|
|
2023
Q3 | $2.41M | Buy |
87,394
+166
| +0.2% | +$4.57K | 0.06% | 421 |
|
|
2023
Q2 | $2.96M | Buy |
87,228
+5,862
| +7% | +$199K | 0.07% | 396 |
|
|
2023
Q1 | $2.93M | Buy |
81,366
+47
| +0.1% | +$1.69K | 0.09% | 352 |
|
|
2022
Q4 | $3.62M | Sell |
81,319
-31
| -0% | -$1.38K | 0.1% | 334 |
|
|
2022
Q3 | $2.29M | Buy |
81,350
+57,034
| +235% | +$1.6M | 0.07% | 395 |
|
|
2022
Q2 | $656K | Sell |
24,316
-201
| -0.8% | -$5.42K | 0.02% | 519 |
|
|
2022
Q1 | $835K | Sell |
24,517
-3,641
| -13% | -$124K | 0.02% | 517 |
|
|
2021
Q4 | $1.09M | Buy |
+28,158
| New | +$1.09M | 0.02% | 506 |
|